Phase I trial of irinotecan (CPT-11) combined with cisplatin (C) given once every three weeks to patients with solid tumors

ANNALS OF ONCOLOGY(1998)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要